Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Weaver

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Pharmacotherapy|December 1, 2025
Developing a Statistical Modeling-Based Machine Learning Approach for Capturing Drug Dosing Using a Proton Pump Inhibitor CaseAmanda Massmann, Jordan F Baye, Max Weaver
Journal of the American Pharmacists Association : Japha|August 15, 2025
Evaluation of the Impact of CYP2D6 Testing on Outcomes in Patients Taking OpioidsHalle Brady, Max Weaver, Jordan Baye, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 9, 2025
Aripiprazole and CYP2D6: A retrospective cohort study evaluating the impact of CYP2D6 phenotype on metabolic abnormalitiesBrian R Meissner, Fatme Younes, Amanda Massmann, et al.
Clinical and Translational Science|March 9, 2026
Clinician Satisfaction With Pharmacogenomics Clinical Services at a Multistate Health SystemKristen Jacobsen, Natasha J Petry, Max Weaver, et al.
JAMIA Open|October 6, 2025
Analyzing the impact of pharmacogenomics-guided nonsteroidal anti-inflammatory drug alerts in clinical practiceAmanda Massmann, Natasha J Petry, Max Weaver, et al.
Pharmacogenomics|March 21, 2025
Impact of a pharmacogenomics (PGx) clinic on patient satisfaction and PGx literacyAmanda Massmann, Jordan Baye, Max Weaver, et al.
The Pharmacogenomics Journal|May 21, 2026
Genotype influences antidepressant discontinuation in a pre-emptive pharmacogenetic testing populationJordan F Baye, Natasha J Petry, Lindsay Hines, et al.
Pharmacogenomics|September 11, 2024
Evaluation of pharmacogenetic automated clinical decision support for clopidogrelAmanda Massmann, Joel Van Heukelom, Max Weaver, et al.
Frontiers in Cardiovascular Medicine|June 22, 2026
Addition of CAD polygenic risk score to coronary artery calcium score enhances prediction of MACEAndrii Maryniak, Filip Oleszak, Kevin Coy, et al.
European Journal of Human Genetics : EJHG|February 29, 2024
Clinical impact of preemptive pharmacogenomic testing on antiplatelet therapy in a real-world settingAmanda Massmann, Kurt D Christensen, Joel Van Heukelom, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Pharmacotherapy|December 1, 2025
Developing a Statistical Modeling-Based Machine Learning Approach for Capturing Drug Dosing Using a Proton Pump Inhibitor CaseAmanda Massmann, Jordan F Baye, Max Weaver
Journal of the American Pharmacists Association : Japha|August 15, 2025
Evaluation of the Impact of CYP2D6 Testing on Outcomes in Patients Taking OpioidsHalle Brady, Max Weaver, Jordan Baye, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 9, 2025
Aripiprazole and CYP2D6: A retrospective cohort study evaluating the impact of CYP2D6 phenotype on metabolic abnormalitiesBrian R Meissner, Fatme Younes, Amanda Massmann, et al.
Clinical and Translational Science|March 9, 2026
Clinician Satisfaction With Pharmacogenomics Clinical Services at a Multistate Health SystemKristen Jacobsen, Natasha J Petry, Max Weaver, et al.
JAMIA Open|October 6, 2025
Analyzing the impact of pharmacogenomics-guided nonsteroidal anti-inflammatory drug alerts in clinical practiceAmanda Massmann, Natasha J Petry, Max Weaver, et al.
Pharmacogenomics|March 21, 2025
Impact of a pharmacogenomics (PGx) clinic on patient satisfaction and PGx literacyAmanda Massmann, Jordan Baye, Max Weaver, et al.
The Pharmacogenomics Journal|May 21, 2026
Genotype influences antidepressant discontinuation in a pre-emptive pharmacogenetic testing populationJordan F Baye, Natasha J Petry, Lindsay Hines, et al.
Pharmacogenomics|September 11, 2024
Evaluation of pharmacogenetic automated clinical decision support for clopidogrelAmanda Massmann, Joel Van Heukelom, Max Weaver, et al.
Frontiers in Cardiovascular Medicine|June 22, 2026
Addition of CAD polygenic risk score to coronary artery calcium score enhances prediction of MACEAndrii Maryniak, Filip Oleszak, Kevin Coy, et al.
European Journal of Human Genetics : EJHG|February 29, 2024
Clinical impact of preemptive pharmacogenomic testing on antiplatelet therapy in a real-world settingAmanda Massmann, Kurt D Christensen, Joel Van Heukelom, et al.
Pageof 1